Processa Pharmaceuticals ...

NASDAQ: PCSA · Real-Time Price · USD
0.25
0.01 (2.71%)
At close: May 23, 2025, 12:58 PM

Processa Pharmaceuticals Statistics

Share Statistics

Processa Pharmaceuticals has 11.88M shares outstanding. The number of shares has increased by 29.84% in one year.

Shares Outstanding 11.88M
Shares Change (YoY) 29.84%
Shares Change (QoQ) 0.34%
Owned by Institutions (%) 4.19%
Shares Floating n/a
Failed to Deliver (FTD) Shares 10,018
FTD / Avg. Volume 0.39%

Short Selling Information

The latest short interest is 70.23K, so 1.33% of the outstanding shares have been sold short.

Short Interest 70.23K
Short % of Shares Out 1.33%
Short % of Float 1.49%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is -0.23 and the forward PE ratio is -0.28. Processa Pharmaceuticals's PEG ratio is 0.

PE Ratio -0.23
Forward PE -0.28
PS Ratio 0
Forward PS 0
PB Ratio 1.59
P/FCF Ratio -0.24
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Processa Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.04.

Current Ratio 1.22
Quick Ratio 1.22
Debt / Equity 0.04
Debt / EBITDA -0.01
Debt / FCF -0.01
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-1,185,011.8
Employee Count 10
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -86.36% in the last 52 weeks. The beta is 1.35, so Processa Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.35
52-Week Price Change -86.36%
50-Day Moving Average 0.3
200-Day Moving Average 0.87
Relative Strength Index (RSI) 44.62
Average Volume (20 Days) 2,598,738

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -12.05M
Net Income -11.85M
EBITDA -11.85M
EBIT -11.85M
Earnings Per Share (EPS) -3.62
Full Income Statement

Balance Sheet

The company has 1.19M in cash and 73.51K in debt, giving a net cash position of 1.12M.

Cash & Cash Equivalents 1.19M
Total Debt 73.51K
Net Cash 1.12M
Retained Earnings -87.22M
Total Assets 4.81M
Working Capital 2.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.25M and capital expenditures -3.24K, giving a free cash flow of -11.25M.

Operating Cash Flow -11.25M
Capital Expenditures -3.24K
Free Cash Flow -11.25M
FCF Per Share -3.68
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PCSA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for PCSA is $6, which is 2400% higher than the current price. The consensus rating is "Buy".

Price Target $6
Price Target Difference 2400%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Jan 22, 2024. It was a backward split with a ratio of 1:20.

Last Split Date Jan 22, 2024
Split Type backward
Split Ratio 1:20

Scores

Altman Z-Score -30.63
Piotroski F-Score 1